Non-small cell lung cancer (NSCLC) is the most common type of lung cancer. It has become evident that somatic mutations and rearrangements in many different genes have been found in lung cancer cells, including EGFR, KRAS, HER2, MET and BRAF. The status of genetic mutations can influence response to targeted therapy. Testing for these mutations and tailoring therapy accordingly are widely accepted as standard practice. Atila Biosystems digital PCR (dPCR) NSCLC mutation screening kit identifies possible 99 mutation sites in two wells in a rapid and cost-effective manner.
For more information on Atila dPCR Lung Cancer Mutation Screening Kit , email

Detect lung cancer mutations early to save lives. My father died of lung cancer at 64 yrs of age and it was only detected with MRI and CAT scans.